Every 8-K that ALLURION TECHNOLOGIES NEW (ALURD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ALURD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALURD filings page.
Allurion Technologies, Inc. (ALUR) reports the resignation of two directors and a reduction in board size. On August 17, 2026, Krishna Gupta, a Class I director and member of the Nominating and Corporate Governance Committee, resigned from the board and that committee. On August 19, 2026, Michael Davin, a Class III director, resigned from the board and from his roles as Chairman of the Compensation Committee and member of the Audit Committee. In connection with these departures, the board approved a reduction in its size from five members to three members.
Allurion Technologies, Inc. entered into an exchange agreement with RTW-affiliated stockholders on July 21, 2026, under which they exchanged an aggregate of 392,766 shares of common stock for pre-funded warrants to purchase an equal number of shares. The warrants have a $0.0001 per share exercise price, are immediately exercisable, and include a beneficial ownership limitation initially set at 9.99% of outstanding common stock, adjustable up to 19.99% upon 61 days’ written notice.
Each warrant will automatically terminate upon foreclosure on collateral securing Allurion’s Revenue Interest Financing Agreements or its 6% Convertible Secured Notes due 2031, upon specified bankruptcy events, or at the holder’s election. Affiliates of RTW Investments, LP, which hold these instruments, beneficially owned approximately 38% of Allurion’s outstanding common stock prior to the exchange. Allurion also received notice terminating a November 11, 2025 Securities Purchase and Exchange Agreement that would have exchanged certain indebtedness for Series B Perpetual Convertible Preferred Stock; because closing did not occur by February 28, 2026, the agreement became void with no termination penalty, and the related indebtedness, including amounts under the revenue interest agreements and convertible notes, remains outstanding on its original terms. The exchange relied on the Section 3(a)(9) exemption for transactions with existing security holders.
Allurion Technologies, Inc. stated that Chief Executive Officer and board member Shantanu K. Gaur, M.D. resigned his positions effective immediately on July 17, 2026. The company reported that his resignation was not the result of any disagreement regarding operations, policies or practices.
The board of directors has not appointed an interim or permanent Chief Executive Officer. Chief Operating Officer Ojas Buch is overseeing day-to-day operations and certain responsibilities previously performed by Dr. Gaur, while his title and compensation arrangements remain unchanged.
Allurion Technologies, Inc. reported that director Douglas Hudson, a Class II member of the board, resigned from the board and from the Nominating and Corporate Governance Committee effective June 30, 2026. The company stated that his resignation was not due to any disagreement with management, the board, or company policies or practices. The board is evaluating which current director will be appointed to replace him on the Nominating and Corporate Governance Committee.